Edgewise Therapeutics, Inc.
USD39.75
+0.94 (+2.41%)
CEO
Kevin Koch
IPO Date
2021-03-26
Sector
Healthcare
Industry
Biotechnology
Exchange
NASDAQ
Country
US
Open
$38.81
Prev. Close
$38.81
Day Low
$38.81
Day High
$39.86
52W Low
$12.30
52W High
$48.40
Market Cap
$4.28B
Volume
0.04M
| 130,352 |
| $0.45 |
| 2 Jul 2026 | Russell Alan J | director, officer: Chief Scientific Officer | M-Exempt | Acquired | 69,648 | $0.18 |
| 2 Jul 2026 | Russell Alan J | director, officer: Chief Scientific Officer | S-Sale | Disposed | 130,352 | $39.41 |
| 2 Jul 2026 | Russell Alan J | director, officer: Chief Scientific Officer | S-Sale | Disposed | 69,648 | $39.41 |
| 2 Jul 2026 | Russell Alan J | director, officer: Chief Scientific Officer | M-Exempt | Disposed | 130,352 | $0.45 |
| 2 Jul 2026 | Russell Alan J | director, officer: Chief Scientific Officer | M-Exempt | Disposed | 69,648 | $0.18 |
| 1 Jul 2026 | Fox Jonathan C | director | A-Award | Acquired | 319 | $0.00 |
| 17 Jun 2026 | Brege Laura | director | A-Award | Acquired | 16,377 | $35.59 |
| 17 Jun 2026 | Thompson Peter A. | director, 10 percent owner: | A-Award | Acquired | 16,377 | $35.59 |